Congress leader Rahul Gandhi on Sunday condemned the Union Government’s handling of the COVID-19 crisis in India. Taking to Twitter, he shared a BBC video showing how India responded to the pandemic crisis. The video briefed about various aspects of India’s response to COVID-19 ranging from the plight of migrant workers after a nationwide lockdown ...

 New Delhi is collaborating with Bhutan to carry out Phase-3 trials of Covid-19 vaccine candidate, while India has sent seven medical aid consignments to the ally nation since March 2020 to support Bhutan in its fight against Coronavirus pandemic. The consignments constitute essential Covid-19 medications including Paracetamol, Hydroxychloroquine and Cetrizine. Apart from medications India also ...

On Monday Union Health Minister Dr. Harsh Vardhan said that India’s first vaccine for Covid-19 is likely to be roll out for public use in first quarter of 2021. Dr. Vardhan said, “Research to develop vaccine is being done expeditiously. There are at least three viable such vaccine candidates that are in the phase of ...

In the midst of the COVID-19 pandemic, India looking forward to the Oxford-AstraZeneca vaccine and it’s likely that the first shot accessible for Indians will be available by the end of 2020. There are two more candidates for indigenously developed vaccines, which are anticipated to begin in a few weeks if they clear the trials, ...

India is looking for successfully performing covid-19 vaccine candidate all across the world to strike a deal with the best ones. So far, India’s list of possible acquisitions include the under-trail candidates being developed by UK’s Oxford-AstraZeneca and United States’s Moderna-NIAID. Besides, the government is also closely observing the progress of vaccine candidates being developed ...

Prime Minister, Narendra Modi during his Independence Day address from the Red Fort stated that three coronavirus vaccines are under trial. As soon as the researchers give a green signal, the nation will start its large scale manufacturing. When all tests are completed, the roadmap of production and delivery to the general public will soon ...

India will be using a digital infrastructure for the dissemination and inventory management of the novel Covid-19 virus vaccine once it becomes available. It is also devising a fool proof method of procurement including both indigenous and international. This will also include guiding principles to prioritize focus groups. The national expert group on vaccine administration ...

As the race across nations intensifies to come up with a vaccine to the Covid-19 virus, India is now moving ahead with its plans to give quick approvals to the Serum Institute of India that is now reaching its Phase 3 of vaccine trials. On trial is the promising Covid-19 vaccine that has been developed ...

The trials of the world’s first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University have been effectively completed. Elena Smolyarchuk, the chief researcher at the university, told Tass news on Sunday that the research and the final results of the vaccine came out effective. In the month of March, the World Health Organization (WHO) ...

With the development of the triple antigen vaccine prototype, Gurgaon-based Premas Biotech is the latest entrant in the COVID-19 vaccine development race. Premas Biotech is however developing a multi sub-unit triple antigen vaccine. This is unlike the other pharma companies across the world who are doing trials for single-protein vaccines. This vaccine prototype is amongst ...